Validation of ten noninvasive diagnostic models for prediction of liver fibrosis in patients with chronic hepatitis B

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Cheng, Jieyao ^a   Hou, Jinlin ^b   Ding, Huiguo ^c   Chen, Guofeng ^d   Xie, Qing ^e   Wang, Yuming ^f   Zeng, Minde ^g   Ou, Xiaojuan ^a   Ma, Hong ^a   Jia, Jidong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d BEIJING 302 HOSPITAL   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

^f THIRD MILITARY MEDICAL UNIVERSITY   (China)

^g SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CHINESE; CHRONIC HEPATITIS B; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELASTOGRAPH; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; BIOPSY; ELASTOGRAPHY; HEPATITIS B, CHRONIC; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PROCEDURES; SURGERY;

ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; ASPARTATE AMINOTRANSFERASES; BIOPSY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; REPRODUCIBILITY OF RESULTS;

EID: 84957564464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144425     Document Type: Article

References (26)

1. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57:167-185. doi: 10.1016/j.jhep.2012.02.010 PMID: 22436845
2. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20:15-20. PMID: 8020885
3. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology 2009; 49:1017-1044. doi: 10.1002/hep.22742 PMID: 19243014
4. Cheng JY, Wang TL, Zhao XY, Shi XY, Hu DD, Ma H. [Analysis of liver specimen quality using 280 specimens obtained by routine puncture biopsy]. Chin J Hepatol 2014; 22:231-232.
5. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526. PMID: 12883497
6. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075. PMID: 11297957
7. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Ledinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29:242-247. doi: 10.1111/j.1478-3231.2008.01802.x PMID: 18637064
8. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAgpositive patients with chronic hepatitis B by a noninvasive model. Hepatology 2005; 42:1437-1445. PMID: 16317674
9. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289-293. PMID: 8690394
10. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43 (6): 1317-1325. PMID: 16729309
11. Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005; 100:616-623. PMID: 15743360
12. Lee HJ, Seo YS, Kim DJ, Kang HS, An H, Kim JH, et al. Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B. J Gastroenterol Hepatol 2011; 26:987-995. doi: 10.1111/j.1440-1746.2010.06609.x PMID: 21198828
13. Zhou K, Gao CF, Zhao YP, Liu HL, Zheng RD, Xian JC, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 2010; 25:1569-1577. doi: 10.1111/j.1440-1746.2010.06383.x PMID: 20796157
14. Zhang WS, Wang BE, Wang TL, Ou XJ, Chen Y, Li Q, et al. [Noninvasive assessment of liver fibrosis in chronic hepatitis B using a predictive model]. Chin J Hepatol 2006; 14:169-173.
15. Wu SD, Liu LL, Li L, Zhu XY, Wang JY. Development and Validation of Noninvasive Models to Predict Significant Fibrosis in Patients with Chronic Hepatitis B. Chin J Dig 2010; 30:478-480.
16. Liu WP, Xu DJ, Zhao LR, Lu ZH, Wang YH, Lang ZW, et al. [The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B]. Zhonghua Nei Ke Za Zhi 2008; 47:308-312. PMID: 18843956
17. Park SH, Kim DJ, Cheong JY, Cho SW, Hwang SG, Lee YJ, et al. Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy. Clin Biochem 2010; 43:877-881. doi: 10.1016/j.clinbiochem.2010.04.063 PMID: 20433821
18. Chen YP, Dai L, Wang JL, Zhu YF, Feng XR, Hou JL. Model consisting of ultrasonographic and simple blood indexes accurately identify compensated hepatitis B cirrhosis. J Gastroenterol Hepatol 2008; 23:1228-1234. doi: 10.1111/j.1440-1746.2008.05421.x PMID: 18637057
19. Tu XL, Xiao YQ, Chen F, Chen JL, Chen HY. A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B. Chin J Hepatol 2009; 17:28-32.
20. Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, et al. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol 2006; 101:2537-2545. PMID: 17029616
21. Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int 2007; 27:969-976. PMID: 17696936
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845. PMID: 3203132
23. Wu SD, Wang JY, Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study. World J Gastroenterol 2010; 16:501-507. PMID: 20101779
24. Kim BK, Kim SU, Kim HS, Park JY, Ahn SH, Chon CY, et al. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One 2012; 7:e35825. doi: 10.1371/journal.pone.0035825 PMID: 22536445
25. Chen XB, Zhu X, Chen LY, Chen EQ, Tang H. Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B. Chin J Hepatol 2011; 19:286-290.
26. Friedrich-Rust M, Rosenberg W, Parkes J, Herrmann E, Zeuzem S, Sarrazin C. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol 2010; 10:103. doi: 10.1186/1471-230X-10-103 PMID: 20828377